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Abstract 
In the current study forty eight compounds belonging to anthraquinones, naphthoquinones, benzoquinones, fla-
vonoids (chalcones and polymethoxylated flavones) and diterpenoids (clerodanes and kauranes) were explored for 
their antimicrobial potential against a panel of sensitive and multi-drug resistant Gram-negative and Gram-positive 
bacteria. The minimal inhibitory concentration (MIC) determinations on the tested bacteria were conducted using 
modified rapid INT colorimetric assay. To evaluate the role of efflux pumps in the susceptibility of Gram-negative 
bacteria to the most active compounds, they were tested in the presence of phenylalanine arginine β-naphthylamide 
(PAβN) (at 30 µg/mL) against selected multidrug resistance (MDR) bacteria. The anthraquinone, emodin, naph-
thaquinone, plumbagin and the benzoquinone, rapanone were active against methicillin resistant Staphylococcus 
aureus (MRSA) strains of bacteria with MIC values ranging from 2 to 128 μg/mL. The structure activity relationships of 
benzoquinones against the MDR Gram-negative phenotype showed antibacterial activities increasing with increase in 
side chain length. In the chalcone series the presence of a hydroxyl group at C3′ together with a methoxy group and 
a second hydroxyl group in meta orientation in ring B of the chalcone skeleton appeared to be necessary for minimal 
activities against MRSA. In most cases, the optimal potential of the active compounds were not attained as they were 
extruded by bacterial efflux pumps. However, the presence of the PAβN significantly increased the antibacterial activi-
ties of emodin against Gram-negative MDR E. coli AG102, 100ATet; K. pneumoniae KP55 and KP63 by >4–64 g/mL. The 
antibacterial activities were substantially enhanced and were higher than those of the standard drug, chlorampheni-
col. These data clearly demonstrate that the active compounds, having the necessary pharmacophores for antibacte-
rial activities, including some quinones and chalcones are substrates of bacterial efflux pumps and therefore should 
be combined to efflux pump inhibitors in the fight against MDR bacterial infections.
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Background
Multidrug resistance (MDR) in bacteria is usually medi-
ated by the expression of efflux pumps or porins involved 
in transport, by the expression of mutated genes coding 
for specific drug targets or specific enzymatic barriers. 
As a matter of fact, MDR remains a major obstacle hin-
dering successful antibacerial chemotherapy (Alekshun 
and Levy 2007; Davin-Regli et al. 2008; Nikaido 2009).
One way of tackling the emergence of MDR is to diver-
sify the chemical structures of anti-microbial drugs to 
which resistance has developed in order to extend their 
lifespan (De Clercq 2001; Poole 2001; Jeu et  al. 2003). 
Alternatively, the compounds exhibiting modest to sig-
nificant antibacterial activities against MDR phenotypes, 
could be used in combination with the efflux inhibitors, 
in order to improve on the accumulation of the drug in 
the cells for optimal activities (Kuete et al. 2011). It is not 
surprising that in response to anti-microbial resistance, 
major pharmaceutical companies have concentrated their 
efforts on improving chemotherapeutic agents in estab-
lished drug classes (Taylor et  al. 2002). However, with 
the portfolio of antimicrobials currently available, most 
of the lead structures of current drugs have already been 
explored. Today, large-scale empirical screening of syn-
thetic, semi-synthetic and natural chemical entities in 
chemical libraries for anti-microbial activities is inves-
tigated (Kimberlin and Whitley 1996). The compounds 
of interest for the development of novel drugs include 
those that target different proteins or biochemical pro-
cesses compared to those in current use and those that 
inhibit bacterial efflux pumps (Kuete et  al. 2011). Natu-
ral products have been a particularly rich source of anti-
infective agents, yielding, for example, the penicillins in 
1940, the tetracyclines in 1948 and the glycopeptides in 
1955 (Silver and Bostian 1990). In the current study the 
antibacterial activities of compounds from several fami-
lies (anthraquinones, naphthoquinones, benzoquinones, 
chalcones, flavones, flavanones, clerodane, and kaurane 
diterpenoids) were determined against different bacte-
rial strains expressing MDR phenotypes. Furthermore, 
the chemical moieties relevant for pharmacophore bind-
ing were analyzed by their structure activity relationships 
(SAR) studies of related compounds.
Results and discussion
Studied compounds
The natural and modified compounds investigated in 
the current study were previously isolated from Kenyan 
plants (Figs.  1, 2). These included quinones; four anth-
raquinones namely; chrysophanol (1) (Fairbairn and El-
Muhtadi 1972; Midiwo and Rukunga 1985; Zhang et  al. 
2012), emodin (2) (Munavu et al. 1984; Chang et al. 1996), 
3,6,8-trihydroxy-1-methylanthraquinone-2-carboxylic 
acid; Me ester (3) (Mehandale et  al. 1968; Dagne et  al. 
1996), aloesaponol I; (-)-form (4) (Yagi et al. 1978; Dagne 
et  al. 1992; Midiwo et  al. 1997), a naphthoquinones; 
5 - h y d r o x y - 2 - m e t h y l - 1 , 4 - n a p h t h a l e n e d i o n e , 
plumbagin (5) (Sidhu et al. 1968; Yuan and Chao 2007), 
thirteen related benzoquinones; 2,5-dihydroxy-3-ethyl- 
2,5-cyclohexadiene-1,4-dione (6) (Khurana et  al. 1972) 
and synthetic derivatives, 2,5-dihydroxy-3-propyl- 
2,5-cyclohexadiene-1,4-dione (7), 2,5-dihydroxy-3-butyl- 
2,5-cyclohexadiene-1,4-dione (8), 2,5-dihydroxy-3- 
heptyl-2,5-cyclohexadiene-1,4-dione (9), 2,5-dihydroxy- 
3-nonyl-2,5-cyclohexadiene-1,4-dione, homoembelin 
(10) (Murthy et  al. 1965), 2,5-dihydroxy-3-tride-
cyl-2,5-cyclohexadiene-1,4-dione, rapanone (11) 
(Wouters and Verhecken 1987), 2,5-dihydroxy-3-pen-
tadecyl-2,5-cyclohexadiene-1,4-dione (12) (Ogawa 
and Natori 1965, 1968a), 2-hydroxy-5-methoxy-3-unde-
cyl-1,4-benzoquinone, 5-O-methylembelin (13) (Merian 
and Schlittler 1948), 2,5-dimethoxy-3-undecyl-1,4-ben-
zoquinone, 2,5-di-O-dimethylembelin (2,5-dimethoxy-
3-undecyl-[1,4]-benzoquinone) (14) (Wu et  al. 2009), 
2,5-dihydroxy-3-methyl-6-(14-nonadecenyl)-1,4-benzo-
quinone, maesaquinone (15) (Ogawa and Natori 1965, 
1968a; Ogawa and Natori 1968b; Manguro et al. 2003), 2,5 
dimethoxy-6-(14-nonadecenyl)-1,4-benzoquinone (16), 
1,2,4,5-tetraacetate-3-methyl-6-(14-nonadecenyl)-
cyclohexadi-2,5-diene (17), ardisiaquinone (18) (Yoshihir 
et al. 1968; Ogawa and Natori 1968b), flavonoids including 
six chalcones; 3′,5′-dihydroxy-1′-methoxychalcone (19), 
1′,5′-dihydroxy-3′-methoxychalcone (20), 1′,3′-dihydroxy- 
2′,5′-dimethoxychalcone (21), 5′-hydroxy-1′,3′-dimet- 
hoxychalcone (22), 1′,3′,5′-trihydroxy-2′-methoxy-
chalcone (23), 1,5-diacetate-3′-methoxychalcone (24) 
(Midiwo et al. 1990; 1992), ten polymethoxylated flavones 
and their semi-synthetic derivatives; 5,7-dihydroxy-
3,4-dimethoxyflavone (25), 3,5,4′-trihydroxy-7 methoxy-
flavone (26), 5,7-dihydroxy-3,6,4′-trimethoxyflavone (27), 
5,4′-dihydroxy-3,7-dimethoxyflavone (28), 5-hydroxy-
3,7,4′-trimethoxyflavone (29) (Omosa et  al. 2010), 
3,5,6,7,4′-pentamethoxyflavone (30), 5-hydroxy-2′,3′,4′, 
5′-tetramethoxyflavone (31), 5-hydroxy-7,2′,3′,4′,5′- 
pentamethoxyflavone (32) (Juma et  al. 2001), 5,7- 
diacetate-3,6,4′-trimethoxyflavone (33) semi-synthetic 
derivative of 5,7-dihydroxy-3,6,4′-trimethoxyflavone 
(Omosa et al. 2010), 5,7-diacetate-3,4′-trimethoxyflavone 
(34) a semi-synthetic derivative of 5,7-dihydroxy-
3,4′-trimethoxyflavone; three flavanones; 5,4′-dihy-
droxy-7-methoxyflavanone (35) (Kerubo et  al. 2013), 
3,7-dihydroxy-5,8-dimethoxyflavanone (36), 5,7,4′- 
trihydroxy-3′-prenylflavanone (37) (Nakahara et  al. 
2003); eleven diterpenoids, four clerodane type; dodonic 
acid (38), hautriwaic acid (39), 2β-hydroxyhardwickiic 
acid (40), hautriwaic acid lactone (41) (Omosa et  al. 
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2010), five trachylobane type; 6,17,19-trachylobane-
triol; (ent-6α)-form (42) (Juma et  al. 2006), 2,6,19-tra-
chylobanetriol; (ent-2α,6α)-form (43) (Midiwo et  al. 
1997), 6,18,19-trachylobanetetrol; (ent-6α)-form (44), 
2,18,19-trachylobanetriol; (ent-2α)-form (45), 2,6,18, 
19-trachylobanetetrol; (ent-2β,6α)-form (46) (Juma et al. 
2006) and two kaurane type; ent-kaur-16-en-2α,18,19-
triol (47), ent-kaur-16-en-18,19-diol (48) (Midiwo et  al. 
1997) Figs. 1 and 2. 
The compounds were tested for their ability to pre-
vent the growth of MDR and reference strains of Gram-
negative bacteria, alone and for some of the active 
compounds, in the presence of the efflux pump inhibitor 
(EPI), PAβN (Table 2).
The antibacterial activity of compounds has been 
defined as significant when the MIC is below 10  µg/
mL, moderate when 10  <  MIC  <  100  µg/mL and low 






















































































































































Fig. 1 Chemical structures of the compounds tested; 1, chrysophanol; 2, emodin; 3, 3,6,8-trihydroxy-1-methylanthraquinone-2-carboxylic acid; Me; 
4, aloesaponol I; 5, plumbagin; 6, benzoquinones; 2,5-dihydroxy-3-ethyl-2,5-cyclohexadiene-1,4-dione; 7, 2,5-dihydroxy-3-propyl-2,5-cyclohexadi-
ene-1,4-dione; 8, 2,5-dihydroxy-3-butyl-2,5-cyclohexadiene-1,4-dione; 9, 2,5-dihydroxy-3-heptyl-2,5-cyclohexadiene-1,4-dione; 10, homoembelin; 
11, rapanone; 12, 2,5-dihydroxy-3-pentadecyl-2,5-cyclohexadiene-1,4-dione; 13, 5-O-methylembelin; 14, 2,5-di-O-dimethylembelin; 15, maesaqui-
none; 16, 2,5 dimethoxy-6-(14-nonadecenyl)-1,4-benzoquinone; 17, 1,2,4,5-tetraacetate-3-methyl-6-(14-nonadecenyl)-cyclohexadi-2,5-diene; 18, 
ardisiaquinone; 19, 3′,5′-dihydroxy-1′-methoxychalcone; 20, 1′,5′-dihydroxy-3′-methoxychalcone; 21, 1′,3′-dihydroxy-2′,5′-dimethoxychalcone; 22, 
5′-hydroxy-1′,3′-dimethoxychalcone; 23, 1′,3′,5′-trihydroxy-2′-methoxychalcone; 24, 1,5-diacetate-3′-methoxychalcone
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2010). Compound 1 was inactive against all drug sen-
sitive and resistant bacteria. However, 2 with a simi-
lar skeletal structure as 1 except for the presence of an 
hydroxyl group at C6 was more active exhibiting anti-
microbial activities against Gram-negative E. coli A102 
and AG 100ATet; K. pneumoniae KP55, KP63, E. aero-
genes EA289 with MIC values of 128, 16, 32, 128 and 
128  µg/mL, respectively. This anthraquinone showed 
good activities against MRSA 4, 6 and 8 with MIC val-
ues of 4 (vs 8), 4 (vs 64), 4 (vs 32) μg/mL, respectively, 
more active than the standard drug, chloramphenicol. 
These results are comparable to those obtained by 
Hatano et al. (1999), where emodin exhibited noticeable 
antibacterial effects against four MRSA strains (OM481, 
OM505, OM584, OM623) and one MRSA strain (209P) 
with MIC values of about 64  μg/mL but less sensitive 
against the Gram-negative strains, E. coli K12 and Pseu-
domonas aeruginosa PA01 with MIC  >  128  μg/mL. The 
presence of an hydroxyl group in place of a methyl group 
at C3 or a methyl in place of hydroxyl group at C8 and 
an additional methyl ester (COOMe) group at C7 in 3 
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Fig. 2 Chemical structures of the compounds tested; 25, 5,7-dihydroxy-3,4-dimethoxyflavone; 26, 3,5,4′-trihydroxy-7 methoxyflavone; 27, 
5,7-dihydroxy-3,6,4′-trimethoxyflavone; 28, 5,4′-dihydroxy-3,7-dimethoxyflavone; 29, 5-hydroxy-3,7,4′-trimethoxyflavone; 30, 3,5,6,7,4′-pen-
tamethoxyflavone; 31, 5-hydroxy-2′,3′,4′,5′-tetramethoxyflavone; 32, 5-hydroxy-7,2′,3′,4′,5′-pentamethoxyflavone; 33, 5,7-diacetate-3,6,4′-
trimethoxyflavone; 34, 5,7-diacetate-3,4′-trimethoxyflavone; 35, 5,4′-dihydroxy-7-methoxyflavanone; 36, 3,7-dihydroxy-5,8-dimethoxyflavanone; 
37, 5,7,4′-trihydroxy-3′-prenylflavanone; 38, dodonic acid; 39, hautriwaic acid; 40, 2β-hydroxyhardwickiic acid; 41, hautriwaic acid lactone; 42, 
6,17,19-trachylobanetriol; (ent-6α)-form; 43, 2,6,19-trachylobanetriol; (ent-2α,6α)-form; 44, 6,18,19-trachylobanetetrol; (ent-6α)-form; 45, 2,18,19-tra-
chylobanetriol; (ent-2α)-form; 46, 2,6,18,19-trachylobanetetrol; (ent-2β,6α)-form; 47, ent-kaur-16-en-2α,18,19-triol; 48, ent-kaur-16-en-18,19-diol
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against the MRSA phenotype, as this compound did not 
inhibit these bacteria. However, this compound exhib-
ited minimal antimicrobial activities against the standard 
E. coli ATCC8739 strain with MIC values of 256 µg/mL, 
which was not inhibited by 2. Compound 4, which is a 
derivative of 3 with a slightly different skeletal structure 
in ring A had antimicrobial activities similar to those of 
3, probably due to the total number of hydroxyl groups 
(3), methyl (1) and acetate irrespective of the positions 
of these substituents in the anthroquinone skeleton. Fur-
thermore, the substitution pattern of ring C was similar 
in the two compounds. This compound was also inactive 
against all bacteria strains tested except for the reference 
E. coli ATCC8939 strain with a MIC value of 256 µg/mL.
The naphthoquinone, plumbagin (5) was active against 
both Gram-positive and Gram-negative bacteria tested 
Table 1 Bacterial strains and features
KAN kanamycin, TET tetracycline, CHL chloramphenicol, NOR norfloxacin, AMP ampicillin, MET methicillin, NAL nalidixic acid, STR streptomycin, ATM aztreonam, CEF 
cefalothin, R resistant, MDR multidrug-resistant
Bacterial strain Relevant features Reference
Escherichia coli
ATCC 8739 and ATCC 10536 Reference strains
 AG100 Wild-type E. coli K-12 Viveiros et al. (2005)
 AG100ATet ΔacrAB mutant of AG100; TETR owing to acrF gene markedly overexpressed Elkins and Mullis (2007)
 AG102 AG100 over-expressing AcrAB pump
Enterobacter aerogenes
ATCC 13048 Reference strain
EA-CM64 CHLR variant obtained from Ghisalberti et al. (2005)
EA3 ATCC 13048 overexpressing AcrAB pump Pradel and Pagès (2002)
Clinical MDR isolate exhibiting energy-dependent
Norfloxacin and chloramphenicol efflux with KANR AMPR
NALR STRR TETR
EA27 Clinical MDR isolate exhibiting
Energy-dependent NOR and
CHL efflux; KANR AMPR NALR
STRR TETR




ATCC 11296 Reference strain
Kp55 Clinical MDR isolate, TETR Chevalier et al. (2000)
Kp63 AMPR ATMR CEFR




PA124 MDR clinical isolate Lorenzi et al. (2009)
Staphyloccocus aureus
ATCC1026 Reference strain
SA3 Clinical Laboratory isolate, sensitive to methicilin
SA4
SA11
SA12 Clinical laboratory isolate, METR
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with interesting MIC values ranging from 2 to 64 μg/mL. 
This naphthoquinone exhibited exceptionally good anti-
microbial activities against MRSA 3, 4, 6, 8 compared to 
chloramphenicol with MIC values of 64 (vs >256), 2 (vs 
8), 2 (vs 64) and 2 (vs 32) µg/mL, respectively. The good 
antibacterial activity of this compound is consistent to 
data previously documented (Kuete et  al. 2011). Several 
studies have also demonstrated the potencies of plum-
bagin against bacteria and fungi (Brice 1955; Durga et al. 
1990; Gujar 1990) as well as cancer (Melo et  al. 1974). 
In a separate study the in  vitro antimicrobial activi-
ties of plumbagin against selected microorganisms were 
reported to be significantly higher than the standard 
drug, streptomycin (Jeyachandran et al. 2009). The anti-
bacterial potencies of different related benzoquinones 
were established against both Gram-negative and Gram-
positive bacteria strains. Compounds 6–8 with a 2–4 
carbon alkyl side chain revealed similar activities against 
various microbes with MIC ranging from 16 to 256 µg/
mL. There was a marked improvement of antibacterial 
activities with increasing length of the lipophilic chain to 
7 as shown by 9 exhibiting low MIC values ranging from 
4 to 32 µg/mL.
There was reduced antimicrobial activities with com-
pounds 10 (C9) against most bacteria strains with the 
lowest activity recorded having MIC  ≥  256  µg/mL 
against E. coli ATCC 8739, AG102, AG100ATet; S. aureus 
A4, A11; K. pneumoniae ATCC11296, KP63; P. stuartii 
ATCC29916, NAE16; E. aerogenes EA27 and against all 
strains of MRSA. The activities of compound 11  (C13) 
against specific bacteria was comparable to that of 9 
especially against the Gram-negative E. coli AG100ATet, 
K. pneumoniae KP55, KP63 with MIC values ranging 
from 16 to 32 µg/mL.
This compound exhibited selective activities against 
specific Gram-negative bacteria such as E. coli AG100A-
Tet, K. pneumoniae KP55, KP63 and the Gram-positive 
MRSA 4, 6, 8 some of which were more potent than chlo-
ramphenicol (Table 2).
Increasing chain lengths of the alkyl group from C15 in 
compound 12 to C19 in 15–17 had no effect on further 
improving the activities of compound 11 (C13) against 
most bacteria. However, 17 showed selective activities 
against three strains of MRSA including MRSA4, 6 and 
8. Reduction of the two keto groups of 15 and subsequent 
acetylation at C1, 2, 4, 5 positions as seen in 17 improved 
the antibacterial activities against specific bacteria 
including MRSA 4, 6, 8. The MIC values of 17 against 
MRSA4 and 8 strains were observed to be almost as low 
as those of the standard drug with MIC values of 32 (vs 
8) and 64 (vs 32), respectively (Table 2) while that against 
MRSA6 was more active than the standard drug (16 (vs 
64) µg/mL. This observation could imply that increasing 
the chain length up to C7 probably results in more pro-
found antibacterial activities. Further increases in chain 
length had little effect on the improvement of the anti-
bacterial activities but led to selectivity of the drugs 
towards specific bacteria, as seen in 11–13. The alky-
ldibenzoquinone, ardisiaquinone B (18) with two benzo-
quinone rings at the end of the alkyl chain (C16) showed 
improved activities as compared to the monomeric ben-
zoquinone with a similar number of carbon atoms in 
the lipophilic chain. This compound showed interesting 
activities against all strains of E. coli, K. pneumoniae, P. 
staurtii and MRSA. This compound was also potent 
against P. aeruginosa PA124 and E. aerogenes EA27 but 
seemed to be inactive against Gram-positive S. aureus.
Compound 19 with two hydroxyl groups, one at C3′and 
the other in meta orientation at C5′and one methoxy 
group also in meta orientation to the hydroxyl group at 
C3′, without a substituent at C2′ was active against two 
strains of MRSA 4 and 6. However, interchanging the 
hydroxyl group at C3′ for a methoxy group and vice versa 
completely reduced the antimicrobial activities against 
these two MRSA strains. This may imply that the sub-
stitution pattern of the substituents on ring B where at 
least one hydroxyl group is placed at C3′, an additional 
hydroxyl groups in meta orientation (either at C1′ and 
5′), a methoxy group in meta orientation to the C3′ 
hydroxyl group (either at C1′ and 5′) as observed in 19 
(hydroxyl at C3′, one meta position to have methoxy and 
the other hydroxyl) is important for minimal activities 
against the two strains of MRSA. Compound 21 with two 
methoxy groups and two hydroxyl groups in meta orien-
tation was the most active compound of the evaluated 
chalcones; against the four MRSA strains. The increased 
antibacterial activities of this compound could be attrib-
uted to the additional oxygenation at C2′ position. The 
basic requirement for activities against MRSA strains 
(hydroxyl at C3′, one meta position to have methoxy and 
the other hydroxyl) was observed here too. However, 
more studies need to be undertaken to understand the 
active scaffold in the chalcone skeleton. Compound 22 
with one hydroxyl group at C5′and two methoxy groups 
at C1′ and C3′ did not exhibit any antibacterial activities 
against all the strains of bacteria including MRSA most 
probably due to the lack of the required scaffold. Com-
pound 23 with two hydroxyl group in meta position in 
ring A but was lacking a methoxy group in second meta 
position was inactive against all bacteria tested including 
the MRSA strains, except for the Gram-negative E. aero-
genes, ATCC13048, with minimal activity.
Most of the flavones tested were polymethoxylated 
making them lipophilic and therefore showing minimal 
or no activities against the bacteria tested. Previous stud-
ies have shown that antifungal compounds tend to be 
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more lipophilic compared to antibacterial compounds 
and hence these compounds should be tested for their 
antifungal potential (McClure 1975; Omosa et al. 2014). 
Compound 34 showed minimal activities against spe-
cific bacteria strains with MIC values ranging from 128 
to 256  µg/mL most probably due to increase in hydro-
philicity (Omosa et  al. 2014). The flavanones tested 
were also inactive due to their lipophilicity as shown in 
previous studies. The clerodanediterpenoids were inac-
tive against all bacteria tested except for hautriwaic acid 
(Omosa et  al. 2014) which showed minimal activity 
against some bacterial strains. However, its lactone did 
not exhibit antimicrobial activities ≤256  µg/mL, most 
probably because of increased lipophilicity. The presence 
of a free hydroxyl group at C19 in the clerodane skeleton 
appears to be necessary for minimal activities against S. 
aureus SA 11, 12; K. pneumoniae KP55, 63; P. aeroginosa 
PA01 and E. aerogenes ATCC 13048 strains. The kaurane 
type diterpenoids exhibited similar antimicrobial pro-
file as the clerodanes which could be attributed to their 
lipophilicity.
Role of efflux pumps in the susceptibility of tested bacteria
In this study the compounds that attained certain thresh-
old of activities including the anthraquinone, 2; naph-
thaquinone, 5; and some benzoquinones, 6–10, 13 and 
18 were combined with the efflux pump inhibitor, EPI, 
PAβN, in order to assess the involvement of efflux in the 
activities of these compounds. When tested alone com-
pound 2 showed minimal antibacterial activities against 
some Gram-negative MDR strains including E. coli 
AG100 and 102, as well as K. pneumoniae KP 55 and K63 
(Table  2). However, there was substantial enhancement 
of activities of 2 with PAβN. The observed MICs without 
PAβN against E. coli AG102, 100ATet; K. pneumoniae KP 
55 and K63 were 128, 16, 32, 128 μg/mL. With PAβN the 
activities improved by >4 fold, exhibiting MICs higher 
than the standard, chloramphenicol of 2, 4, <2 and 2 μg/
mL, respectively (Table 2). This compound which exhib-
ited good antibacterial activities against MDR Gram-
positive bacteria alone also showed improved activities 
in combination with PAβN. However, the improvement 
was not as substantial as that observed against the Gram-
negative bacteria. The naphthaquinone, plumbagin (5) 
which showed good activities even when tested alone 
exhibited minimal improvement with PAβN as compared 
to emodin (2) except against AG100ATet with >8 fold 
increament. These results consistent with those obtained 
by Kuete et al. (2011). The antimicrobial activities against 
the Gram-positive MDR strains increased by >4 fold 
against MRSA 6, 8 and >2 fold for MRSA 4.
The benzoquinones, 6–10 and 18 showed enhance-
ment in activity with PAβN most of which were >2 and 
4 folds, with 13 having MICs  <  10  μg/mL. These data 
clearly demonstrate that the quinones and chalcones 
tested are substrates of bacterial efflux pumps and should 
be combined to EPI in the fight against MDR bacterial 
infections. The obtained results are therefore consist-
ent to data previously reported by Kuete et  al. (2011), 
who highlighted the role of efflux pumps in the bacterial 
resistance to natural products.
Conclusion
In this study, various anthraquinones, naphthoquinones, 
benzoquinones, flavonoids (chalcones and polymeth-
oxylated flavones) and diterpenoids (clerodanes and 
kauranes) were explored for their antimicrobial poten-
tial against different drug sensitive Gram-negative and 
Gram-positive bacteria.
The results show that the anthraquinone (2), naph-
thaquinone, plumbagin (5) benzoquinones (11, 12, 17, 
18), chalcones (19, 21) were active against MRSA bac-
teria strains with MIC value ranging from 2 to 128  µg/
mL. Structure activity relationships of benzoquinones; 
which has not been carried out in previous studies, 
showed that antibacterial activities gradually increased 
with increasing side chain length from 2, 3, 4 for 6, 7 
and 8, respectively, with optimal activities being realized 
with C7 (9). This study also showed that there is a mini-
mum chain length that is required for maximum activ-
ity in the 2,5 dihydroxy-1,4-benzoquinone moieties. This 
studies showed that the minimum chain length required 
for optimal antimicrobial activities was C7 (compound 
9) beyond which no marked activity improvement has 
been observed. Some compounds selectively inhibited 
the growth of specific but not all bacteria. These stud-
ies revealed that the presence of a hydroxyl group at C3′ 
together with a methoxy group and a second hydroxyl 
group in meta orientation in ring B of the chalcone skele-
ton appears to be necessary for minimal activities against 
MRSA 4 and 6 as elaborated in 19–24.
These data clearly demonstrate that the tested com-
pounds are substrates of bacterial efflux pumps and 
should be combined to EPI in the fight against MDR bac-
terial infections. The obtained results are therefore con-
sistent to data previously reported by Kuete et al. (2011), 
who highlighted the role of efflux pumps in bacterial 
resistance to natural products.
Methods
Reagents and compounds
The chemicals used in antimicrobial assays were chloram-
phenicol ≥98  % (Sigma-Aldrich, St-Quentin-Fallavier, 
France) as reference antibiotic and p-Iodonitrotetrazo-
lium chloride ≥97  % (INT, Sigma-Aldrich) as microbial 
growth indicator (Eloff 1998; Mativandlela et  al. 2006). 
Page 14 of 15Omosa et al. SpringerPlus  (2016) 5:901 
Phenylalanine-Arginine-β-Naphthylamide (PAβN; 
Sigma-Aldrich) was used as efflux pumps inhibitor (EPI). 
Natural products (Figs.  1, 2) used in the study were 
obtained from the chemical bank of the natural products 
research laboratory of the Chemistry Department, Uni-
versity of Nairobi, Kenya. Isolation and identification of 
the compounds in study were previously reported from 
the following plants; a number of Rumex species includ-
ing; Rumex dentatus, R. abyssinicus, R. usambarensis, 
R. bequaertii, R. ruwenzoriensis, R. crispus; Plumbago 
zeylanica, Myrsine africana, Maesa lanceolata, Rapa-
nea melanphloes, Aloe saponaria, Erythrina abyssinica, 
Polygonum senegalense, Psiadia punctulata, Dodonaea 
angustifolia and Senecio roseiflorus.
Bacterial strains and culture media
MDR isolates and reference strains of Escherichia coli, 
Enterobacter aerogenes, Pseudomonas aeruginosa, Kleb-
siella pneumoniae and Staphylococcus aureus are sum-
marized in Table 1. Isolates were conserved at 4  °C and 
were grown on Mueller–Hinton agar for 24  h before 
minimal inhibitory concentration (MIC) testing. Muel-
ler–Hinton broth (MHB) was used for the susceptibility 
tests (Kuete et al. 2008).
Determination of bacterial susceptibility
The MIC determinations on the tested bacteria were 
conducted using rapid INT colorimetric assay accord-
ing to described methods (Eloff 1998) with some modi-
fications (Kuete et  al. 2007, 2009). First of all, the test 
samples and reference antibiotic (RA) were dissolved in 
dimethyl sulphoxide (DMSO)/Mueller–Hinton Broth 
(MHB) or DMSO/MHB broth. The final concentration 
of DMSO was lower than 2.5 % and does not affect the 
microbial growth. The solution obtained was then added 
to MHB, and serially diluted two fold (in a 96-wells 
microplate). One hundred microlitrer (100  µL) of inoc-
ulum 1.5 ×  106 CFU/mL prepared in appropriate broth 
was then added. The plates were covered with a ster-
ile plate sealer, then agitated to mix the contents of the 
wells using a plate shaker and incubated at 37 °C for 18 h. 
Wells containing adequate broth, 100  µL of inoculum 
and DMSO to at a final concentration of 2.5  % served 
as negative control. Choramphenicol was used as a RA. 
The minimum inhibition concentration (MIC) of samples 
was detected after 18  h incubation at 37  °C, following 
addition (40 µL) of 0.2 mg/mL of INT and incubation at 
37 °C for 30 min. Viable bacteria reduced the yellow dye 
(TNT) to pink. MIC was defined as the sample concen-
tration that prevented the color change of the medium 
and exhibited complete inhibition of microbial growth 
(Eloff 1998). All assays were carried out in triplicate and 
were repeated three times. To evaluate the role of efflux 
pumps in the susceptibility of Gram-negative bacteria 
to the most active compounds, they were tested in the 
presence of PAβN (at 30  µg/mL) against selected MDR 
phenotypes (Table 2) and MICs were determined as men-
tioned above.
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